-
1
-
-
33747892889
-
Pharmacological treatment of chronic heart failure
-
Adorisio R, De Luca L, Rossi J, Gheorghiade M, (2006) Pharmacological treatment of chronic heart failure. Heart failure reviews 11: 109-123.
-
(2006)
Heart Failure Reviews
, vol.11
, pp. 109-123
-
-
Adorisio, R.1
De Luca, L.2
Rossi, J.3
Gheorghiade, M.4
-
2
-
-
33846857559
-
Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
-
Rosamond W, Flegal K, Friday G, Furie K, Go A, et al. (2007) Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115: e69-171.
-
(2007)
Circulation
, vol.115
-
-
Rosamond, W.1
Flegal, K.2
Friday, G.3
Furie, K.4
Go, A.5
-
3
-
-
33846966331
-
Differences between pathologic and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure
-
McMullen JR, Jennings GL, (2007) Differences between pathologic and physiological cardiac hypertrophy: novel therapeutic strategies to treat heart failure. Clinical and experimental pharmacology & physiology 34: 255-262.
-
(2007)
Clinical and Experimental Pharmacology & Physiology
, vol.34
, pp. 255-262
-
-
McMullen, J.R.1
Jennings, G.L.2
-
5
-
-
34547665415
-
Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface
-
McKinsey TA, Kass DA, (2007) Small-molecule therapies for cardiac hypertrophy: moving beneath the cell surface. Nat Rev Drug Discov 6: 617-635.
-
(2007)
Nat Rev Drug Discov
, vol.6
, pp. 617-635
-
-
McKinsey, T.A.1
Kass, D.A.2
-
6
-
-
81755181690
-
Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors
-
Li C, Li J, Cai X, Sun H, Jiao J, et al. (2011) Protein kinase D3 is a pivotal activator of pathological cardiac hypertrophy by selectively increasing the expression of hypertrophic transcription factors. J Biol Chem 286: 40782-40791.
-
(2011)
J Biol Chem
, vol.286
, pp. 40782-40791
-
-
Li, C.1
Li, J.2
Cai, X.3
Sun, H.4
Jiao, J.5
-
7
-
-
62349105876
-
Cardiac regulation by phosphoinositide 3-kinases and PTEN
-
Oudit GY, Penninger JM, (2009) Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovascular research 82: 250-260.
-
(2009)
Cardiovascular Research
, vol.82
, pp. 250-260
-
-
Oudit, G.Y.1
Penninger, J.M.2
-
8
-
-
0242381308
-
Phosphoinositide 3-kinase γ-deficient mice are protected from isoproterenol-induced heart failure
-
Oudit GY, Crackower MA, Eriksson U, Sarao R, Kozieradzki I, et al. (2003) Phosphoinositide 3-kinase γ-deficient mice are protected from isoproterenol-induced heart failure. Circulation 108: 2147-2152.
-
(2003)
Circulation
, vol.108
, pp. 2147-2152
-
-
Oudit, G.Y.1
Crackower, M.A.2
Eriksson, U.3
Sarao, R.4
Kozieradzki, I.5
-
9
-
-
34247877577
-
The fuzzy logic of physiological cardiac hypertrophy
-
Dorn GW 2nd, (2007) The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49: 962-970.
-
(2007)
Hypertension
, vol.49
, pp. 962-970
-
-
Dorn 2nd, G.W.1
-
10
-
-
64249125022
-
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial
-
O'Connor CM, Whellan DJ, Lee KL, Keteyian SJ, Cooper LS, et al. (2009) Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial. JAMA: the journal of the American Medical Association 301: 1439-1450.
-
(2009)
JAMA: The Journal of the American Medical Association
, vol.301
, pp. 1439-1450
-
-
O'Connor, C.M.1
Whellan, D.J.2
Lee, K.L.3
Keteyian, S.J.4
Cooper, L.S.5
-
11
-
-
77954936825
-
Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis
-
Davies EJ, Moxham T, Rees K, Singh S, Coats AJ, et al. (2010) Exercise training for systolic heart failure: Cochrane systematic review and meta-analysis. European journal of heart failure 12: 706-715.
-
(2010)
European Journal of Heart Failure
, vol.12
, pp. 706-715
-
-
Davies, E.J.1
Moxham, T.2
Rees, K.3
Singh, S.4
Coats, A.J.5
-
12
-
-
78650121847
-
Molecular distinction between physiological and pathologic cardiac hypertrophy: experimental findings and therapeutic strategies
-
Bernardo BC, Weeks KL, Pretorius L, McMullen JR, (2010) Molecular distinction between physiological and pathologic cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacology & therapeutics 128: 191-227.
-
(2010)
Pharmacology & Therapeutics
, vol.128
, pp. 191-227
-
-
Bernardo, B.C.1
Weeks, K.L.2
Pretorius, L.3
McMullen, J.R.4
-
13
-
-
10744223902
-
The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway
-
McMullen JR, Shioi T, Huang WY, Zhang L, Tarnavski O, et al. (2004) The insulin-like growth factor 1 receptor induces physiological heart growth via the phosphoinositide 3-kinase(p110alpha) pathway. The Journal of biological chemistry 279: 4782-4793.
-
(2004)
The Journal of Biological Chemistry
, vol.279
, pp. 4782-4793
-
-
McMullen, J.R.1
Shioi, T.2
Huang, W.Y.3
Zhang, L.4
Tarnavski, O.5
-
14
-
-
0034213075
-
The conserved phosphoinositide 3-kinase pathway determines heart size in mice
-
Shioi T, Kang PM, Douglas PS, Hampe J, Yballe CM, et al. (2000) The conserved phosphoinositide 3-kinase pathway determines heart size in mice. The EMBO journal 19: 2537-2548.
-
(2000)
The EMBO Journal
, vol.19
, pp. 2537-2548
-
-
Shioi, T.1
Kang, P.M.2
Douglas, P.S.3
Hampe, J.4
Yballe, C.M.5
-
15
-
-
33846318098
-
Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy
-
McMullen JR, Amirahmadi F, Woodcock EA, Schinke-Braun M, Bouwman RD, et al. (2007) Protective effects of exercise and phosphoinositide 3-kinase(p110alpha) signaling in dilated and hypertrophic cardiomyopathy. Proc Natl Acad Sci USA 104: 612-617.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 612-617
-
-
McMullen, J.R.1
Amirahmadi, F.2
Woodcock, E.A.3
Schinke-Braun, M.4
Bouwman, R.D.5
-
16
-
-
33745946911
-
Therapeutic potential of Toll-like receptor 9 activation
-
Krieg AM, (2006) Therapeutic potential of Toll-like receptor 9 activation. Nature reviews Drug discovery 5: 471-484.
-
(2006)
Nature Reviews Drug Discovery
, vol.5
, pp. 471-484
-
-
Krieg, A.M.1
-
17
-
-
33750515851
-
Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response
-
Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR, (2006) Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response. Cardiovascular research 72: 384-393.
-
(2006)
Cardiovascular Research
, vol.72
, pp. 384-393
-
-
Boyd, J.H.1
Mathur, S.2
Wang, Y.3
Bateman, R.M.4
Walley, K.R.5
-
18
-
-
41149145130
-
Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9
-
Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, et al. (2008) Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: role of toll-like receptor 9. Cardiovascular research 78: 26-35.
-
(2008)
Cardiovascular Research
, vol.78
, pp. 26-35
-
-
Knuefermann, P.1
Schwederski, M.2
Velten, M.3
Krings, P.4
Ehrentraut, H.5
-
19
-
-
34247163179
-
An Andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway
-
Ma D, Tang XD, Rogers TB, Welling PA, (2007) An Andersen-Tawil syndrome mutation in Kir2.1 (V302M) alters the G-loop cytoplasmic K+ conduction pathway. J Biol Chem 282: 5781-5789.
-
(2007)
J Biol Chem
, vol.282
, pp. 5781-5789
-
-
Ma, D.1
Tang, X.D.2
Rogers, T.B.3
Welling, P.A.4
-
20
-
-
77957349183
-
The calcium store sensor, STIM1, reciprocally controls Orai and Cav1.2 channels
-
Wang Y, Deng X, Mancarella S, Hendron E, Eguchi S, et al. (2010) The calcium store sensor, STIM1, reciprocally controls Orai and Cav1.2 channels. Science 330: 105-109.
-
(2010)
Science
, vol.330
, pp. 105-109
-
-
Wang, Y.1
Deng, X.2
Mancarella, S.3
Hendron, E.4
Eguchi, S.5
-
21
-
-
0141963861
-
Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels
-
Tang XD, Xu R, Reynolds MF, Garcia ML, Heinemann SH, et al. (2003) Haem can bind to and inhibit mammalian calcium-dependent Slo1 BK channels. Nature 425: 531-535.
-
(2003)
Nature
, vol.425
, pp. 531-535
-
-
Tang, X.D.1
Xu, R.2
Reynolds, M.F.3
Garcia, M.L.4
Heinemann, S.H.5
-
22
-
-
52549127241
-
Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI3K-mTOR-p70S6K pathway
-
Cao W, Manicassamy S, Tang H, Kasturi SP, Pirani A, et al. (2008) Toll-like receptor-mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI3K-mTOR-p70S6K pathway. Nature immunology 9: 1157-1164.
-
(2008)
Nature Immunology
, vol.9
, pp. 1157-1164
-
-
Cao, W.1
Manicassamy, S.2
Tang, H.3
Kasturi, S.P.4
Pirani, A.5
-
23
-
-
84890560911
-
The TLR9 agonist, CpG-ODN 1826, ameliorates cardiac dysfunction after trauma-hemorrhage
-
Zhang X, Gao M, Ha T, Kalbfleisch JH, Williams DL, et al. (2012) The TLR9 agonist, CpG-ODN 1826, ameliorates cardiac dysfunction after trauma-hemorrhage. Shock.
-
(2012)
Shock
-
-
Zhang, X.1
Gao, M.2
Ha, T.3
Kalbfleisch, J.H.4
Williams, D.L.5
-
24
-
-
84868516625
-
CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling
-
Cao Z, Ren D, Ha T, Liu L, Wang X, et al. (2013) CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling. Biochimica et biophysica acta 1832: 96-104.
-
(2013)
Biochimica Et Biophysica Acta
, vol.1832
, pp. 96-104
-
-
Cao, Z.1
Ren, D.2
Ha, T.3
Liu, L.4
Wang, X.5
-
25
-
-
77955888865
-
TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism
-
Ha T, Hu Y, Liu L, Lu C, McMullen JR, et al. (2010) TLR2 ligands induce cardioprotection against ischaemia/reperfusion injury through a PI3K/Akt-dependent mechanism. Cardiovascular research 87: 694-703.
-
(2010)
Cardiovascular Research
, vol.87
, pp. 694-703
-
-
Ha, T.1
Hu, Y.2
Liu, L.3
Lu, C.4
McMullen, J.R.5
-
27
-
-
34547121683
-
Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism
-
Zhang KR, Liu HT, Zhang HF, Zhang QJ, Li QX, et al. (2007) Long-term aerobic exercise protects the heart against ischemia/reperfusion injury via PI3 kinase-dependent and Akt-mediated mechanism. Apoptosis: an international journal on programmed cell death 12: 1579-1588.
-
(2007)
Apoptosis: An International Journal on Programmed Cell Death
, vol.12
, pp. 1579-1588
-
-
Zhang, K.R.1
Liu, H.T.2
Zhang, H.F.3
Zhang, Q.J.4
Li, Q.X.5
-
28
-
-
37449031461
-
Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB
-
Gupta S, Young D, Maitra RK, Gupta A, Popovic ZB, et al. (2008) Prevention of cardiac hypertrophy and heart failure by silencing of NF-kappaB. Journal of molecular biology 375: 637-649.
-
(2008)
Journal of Molecular Biology
, vol.375
, pp. 637-649
-
-
Gupta, S.1
Young, D.2
Maitra, R.K.3
Gupta, A.4
Popovic, Z.B.5
-
29
-
-
41149165830
-
Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction
-
Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, et al. (2008) Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circulation research 102: 257-264.
-
(2008)
Circulation Research
, vol.102
, pp. 257-264
-
-
Timmers, L.1
Sluijter, J.P.2
van Keulen, J.K.3
Hoefer, I.E.4
Nederhoff, M.G.5
-
30
-
-
0035665486
-
Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system
-
Leenen FH, White R, Yuan B, (2001) Isoproterenol-induced cardiac hypertrophy: role of circulatory versus cardiac renin-angiotensin system. Am J Physiol Heart Circ Physiol 281: H2410-2416.
-
(2001)
Am J Physiol Heart Circ Physiol
, vol.281
-
-
Leenen, F.H.1
White, R.2
Yuan, B.3
-
31
-
-
74549187474
-
Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure
-
Galindo CL, Skinner MA, Errami M, Olson LD, Watson DA, et al. (2009) Transcriptional profile of isoproterenol-induced cardiomyopathy and comparison to exercise-induced cardiac hypertrophy and human cardiac failure. BMC physiology 9: 23.
-
(2009)
BMC Physiology
, vol.9
, pp. 23
-
-
Galindo, C.L.1
Skinner, M.A.2
Errami, M.3
Olson, L.D.4
Watson, D.A.5
|